Article
Splenic marginal zone lymphoma: from genetics to management.
Blood - 28 Apr 2016
Arcaini Luca, Rossi Davide, Paulli Marco
Abstract excerpt
Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy involving the spleen, bone marrow, and frequently the blood. SMZL lymphomagenesis involves antigen and/or superantigen stimulation and molecular deregulation of genes (NOTCH2 and KLF2) involved in the physiological differentiation of spleen marginal zone B cells. Diagnosis requires either spleen histology or, alternatively, the documentation of a...
Topics
- Antineoplastic Combined Chemotherapy Protocols
- Antiviral Agents
- Autoimmune Diseases
- Cell Transformation, Neoplastic
- Combined Modality Therapy
- Diagnosis, Differential
- Disease Management
- Hepatitis C, Chronic
- Humans
- Kruppel-Like Transcription Factors
